
CARRIED INTEREST E PRIVATE CAPITAL: PIANI A RISCHIO DI RIQUALIFICAZIONE
29 Aprile 2026Giovannelli e Associati with Oxevia and its controlling shareholder Systematic Growth in the joining of Alfatest S.r.l. and AlfatestLab S.r.l. to the Oxevia Group
Giovannelli e Associati advised Oxevia and its controlling shareholder Systematic Growth in connection with the joining of Alfatest S.r.l. and AlfatestLab S.r.l. to the Oxevia Group. Oxevia is a pan-European platform delivering instruments, consumables, reagents, and high value-add services, distinguished by its commitment to personal customer service and local scientific expertise, backed and controlled by Systematic Growth. Alfatest is a leading Italian scientific solutions company specialising in material characterisation, nanoscience, and bioscience, distributing a curated portfolio of globally recognised brands and supporting research institutions, pharmaceutical organisations, and industrial customers in accessing the instruments and expertise essential to their work. Through AlfatestLab, its cGMP-certified contract testing laboratory, Alfatest delivers analytical and proof-of-concept services to both industry and academia, drawing on decades of scientific expertise and deep customer relationships.
Giovannelli e Associati assisted Oxevia and Systematic Growth with a multidisciplinary team led by Partner Matteo Colombari, supported by Counsel Giulia Contestabile and Associates Filippo Camerada, Edoardo Pietricola, and Camilla Caliterna for M&A, cross-border, and corporate matters, by Partners Paolo Bertolini and Najwa Hamidallah for regulatory and administrative matters, and by Andrea Scarpellini and Santi Marco Calabrò for employment matters. For cross-border and corporate matters, Oxevia and Systematic Growth were also advised by Swedish law firm Snellman Advokatbyrå AB, with a team led by Partner Miklos Kovacs Scherlin.
Please use the following link for the press review:



